On April 19, 2021, Amgen announced its launch of Biomarker AssistTM—a program to help patients with metastatic non-small cell lung cancer (NSCLC) gain access to biomarker testing. Through this new program, eligible patients may save on costs related to biomarker testing.
Learn more about Biomarker AssistTM on its website.
Read the Amgen announcement.
Posted 4/19/2021
In recognition of Leukemia and Lymphoma Awareness Month, ACCC compiled a group of resources to help care teams navigate two of the most commonly diagnosed adult leukemias: acute myeloid leukemia and chronic lymphocytic leukemia.
